Guidance documents represent the FDA's current thinking on a particular subject. New guidance documents are listed here for three months.

AbbVie inked a deal with the Medicines Patent Pool to boost access to hepatitis C drug Mavyret in nearly 100 low- and middle-income countries and territories.